Activted protein C inhibits thrombus formation in a system with flowing blood

British Journal of Haematology

Volumn 95, Issue 1, 1996, Pages 179-183

  Lozano, M ^a,c   Escolar, G ^a   Schwarz, H P ^b   Hernandez R ^a   Bozzo, J ^a   Ordinas, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

activated protein C; low molecular weight heparin; perfusion; platelet adhesion; thrombosis

Indexed keywords

ACTIVATED PROTEIN C; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C;

ARTICLE; BLOOD FLOW; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOGENESIS; THROMBOSIS; ANIMAL; BLOOD; BLOOD CLOTTING; BLOOD FLOW VELOCITY; DRUG EFFECT; FIBRINOLYSIS; HEMOSTASIS; RABBIT; THROMBOCYTE ADHESIVENESS;

ANIMALS; BLOOD COAGULATION; BLOOD FLOW VELOCITY; FIBRINOLYSIS; HEMOSTASIS; PLATELET ADHESIVENESS; PROTEIN C; RABBITS; THROMBOSIS;

EID: 0029662192     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1870.x     Document Type: Article

References (31)

1. Arnljots, B. & Dahlback, B. (1995) Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 937-941.
2. Baumgartner, H.R. (1977) Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with α-chymotrypsin digested subendothelium. Thrombosis and Haemostasis. 37, 1-16.
3. Baumgartner, H.R. (1979) Effects of acetylsalicylic acid. sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood. Haemostasis, 8. 340-352.
4. Baumgartner, H.R. & Muggli, R. (1976) Adhesion and aggregation: morphological demonstration and quantitation in vivo and in vitro. Platelets in Biology and Pathology (ed. by J. L. Gordon), p. 23. North-Holland Publishing Company, Amsterdam.
5. Bruhn, H.D., Conard, J., Mannucci, P.M., Monteagudo, J., Pelzer, H., Reverter, J.C., Samama, M., Tripodi, A. & Wagner, C. (1992) Multicentric evaluation of a new assay for prothrombin fragment F1 + 2 determination. Thrombosis and Haemostasis. 68, 413-417.
6. Diquelou, A., Lemozy, S., Dupouy, D., Boneu, B., Sakariassen, K. & Cadroy, Y. (1994) Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood, 84. 2206-2213.
7. Dittman, W.A. & Majerus, P.W. (1990) Structure and function of thrombomodulin: a natural anticoagulant. Blood. 75. 329-336.
8. Dreyfus, M., Magny, J.F., Bridey, F., Schwarz, H.P., Planch, C., Dehan, M. & Tchernia, G. (1991) Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. New England Journal of Medicine, 325. 1565-1568.
9. Escolar, G., Bastida, E., Castillo, R. & Ordinas, A. (1986) Development of a computer program to analyze the parameters of platelet-vessel wall interaction. Haemostasis. 16, 8-14.
10. Esmon, C.T. (1989) The role of protein C and thrombomodulin in the regulation of blood coagulation. Journal of Biological Chemistry. 264, 4743-4746.
11. Fenton, J.W., Ofosu, F.A., Moon, D.G. & Maraganone, J.M. (1991) Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagulation and Fibrinolysis. 2. 69-75.
12. Foster, W.B., Tucker, M.M., Katzmann, J.A., Miller, R.S., Nesheim. M.E. & Mann, K.G. (1983) Monoclonal antibodies to human coagulation factor V and Va. Blood, 61. 1060-1067.
13. Fulcher, C.A., Gardiner, J.E., Griffin, J.H. & Zimmerman, T.S. (1984) Proteolytic inactivation of activated human factor VIII procoagulant protein by activated protein C and its analogy to factor V. Blood, 63. 486-489.
14. Grinnell, B.W., Hermann, R.B. & Yan, S.B. (1994) Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology, 4, 221-225.
15. Gruber, A., Griffin, J.H., Harker, L.A. & Hanson, S.R. (1989) Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood. 73, 639-642.
16. Gruber, A., Hanson, S.R., Kelly, A.B., Yan, B.S., Bang, N., Griffin, J.H. & Harker, L.A. (1990) Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation, 82, 578-585.
17. Hanson, S.R., Griffin, J.H., Harker, L.A., Kelly, A.B., Esmon, C.T. & Gruber, A. (1993) Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. Journal of Clinical Investigation, 92, 2003-2012.
18. Heeb, M.J. & Griffin, J.H. (1988) Physiological inhibition of human activated protein C by alpha 1-antitrypsin. Journal of Biological Chemistry, 263, 11613-11616.
19. Kalafatis, M. & Mann, K.G. (1993) Role of the membrane in the inactivation of factor Va by activated protein C. Journal of Biological Chemistry, 268. 27246-27257.
20. Komoriya, K., Inoue, K., Takahashi, K. & Suzuki, K. (1992) Inhibitory effect of activated protein C on platelet aggregation induced by the prothrombin-converting reaction. Thrombosis Research, 67, 705-710.
21. Lozano, M., Bos, A., de Groot, P.G., van Willigen, G., Meuleman, D.G., Ordinas, A. & Sixma, J.J. (1994) Suitability of low-molecular-weight heparin(oid)s and a pentasaccharide for an in vitro human thrombosis model. Arteriosclerosis and Thrombosis. 14, 1215-1222.
22. Moore, E.W. (1970) Ionized calcium in normal serum, ultrafiltrates and whole blood determined by ion-exchange electrodes. Journal of Clinical Investigation, 49, 318-322.
23. Pichler, L., Schramm, W., Ulrich, W., Varadi, K. & Schwarz, H.P. (1995) Antinociceptive properties of protein C in a model of inflammatory hyperalgesia in rats. Thrombosis and Haemostasis. 73, 252-255.
24. Rezaie, A.R. & Esmon, C.T. (1994) Proline at the P2 position in protein C is important for calcium-mediated regulation of protein C activation and secretion. Blood. 83, 2526-2531.
25. Sakamoto, T., Ogawa, H., Yasue, H., Oda, Y., Kitajima, S., Tsumoto, K. & Mizokami, H. (1994) Prevention of arterial reocclusion after thrombolysis with activated protein C: comparison with heparin in a canine model of coronary artery thrombosis. Circulation. 90, 427-432.
26. Scharf, R.E., Tomer, A., Marzec, U.M., Teirstein, P.S., Ruggeri, Z.M. & Harker, L.A. (1992) Activation of platelets in blood perfusing angioplasty-damaged coronary arteries: flow cytometric detection. Arteriosclerosis and Thrombosis, 12, 1475-1487.
27. Shen, L. & Dahlback, B. (1994) Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. Journal of Biological Chemistry. 269. 18735-18738.
28. Swords, N.A. & Mann, K.G. (1993) The assembly of the prothrombinase complex on adherent platelets. Arteriosclerosis and Thrombosis, 13, 1602-1612.
29. Weinstein, R.E. & Walker, F.J. (1993) Effect of rabbit activated protein C on thrombin generation and fibrinolysis in a species-specific in vivo model: effect of modulation of protein S activity. Seminars in Thrombosis and Hemostasis. 19, 368-377.
30. Yamashita, T., Matsuoka, A., Funatsu, A. & Yamamoto, J. (1994) The antithrombotic effect of human activated protein C on He-Ne laser-induced thrombosis in rat mesenteric microvessels. Thrombosis Research. 75, 33-40.
31. Zwaginga, J.J., Sixma, J.J. & de Groot, P.G. (1990) Activation of endothelial cells induces platelet thrombus formation on their matrix: studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant, Arteriosclerosis, 10, 49-61.